S Ishizuka

Author PubWeight™ 49.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Separation of ionic currents in the somatic membrane of frog sensory neurons. J Membr Biol 1984 1.52
2 Genotype-phenotype correlation of patients with multiple endocrine neoplasia type 2 in Japan. Jpn J Clin Oncol 1998 1.38
3 Bafilomycin A(1) inhibits rhinovirus infection in human airway epithelium: effects on endosome and ICAM-1. Am J Physiol Lung Cell Mol Physiol 2001 1.14
4 GABA activates different types of chloride-conducting receptor-ionophore complexes in a dose-dependent manner. Brain Res 1985 1.11
5 Skin cancer prevention: a possible role of 1,25dihydroxyvitamin D3 and its analogs. J Steroid Biochem Mol Biol 2005 1.10
6 Increased carbon monoxide in exhaled air of subjects with upper respiratory tract infections. Am J Respir Crit Care Med 1998 1.03
7 Diabetic osteopenia and circulating levels of vitamin D metabolites in type 2 (noninsulin-dependent) diabetes. Metabolism 1985 1.00
8 Synthesis, biological evaluation, and conformational analysis of A-ring diastereomers of 2-methyl-1,25-dihydroxyvitamin D(3) and their 20-epimers: unique activity profiles depending on the stereochemistry of the A-ring and at C-20. J Med Chem 2000 0.98
9 Stereochemistry of 25-hydroxyvitamin D3-26,23-lactone and 1 alpha, 25-dihydroxyvitamin D3-26,23-lactone in rat serum. FEBS Lett 1981 0.94
10 Regulation of intracellular polyamine biosynthesis and transport by NO and cytokines TNF-alpha and IFN-gamma. Am J Physiol 1999 0.92
11 Correlations between bone mineral density and circulating bone metabolic markers in diabetic patients. Diabetes Res Clin Pract 2000 0.92
12 Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein. J Steroid Biochem Mol Biol 2001 0.92
13 The stereochemical configuration of the natural 1 alpha,25-dihydroxyvitamin D3-26,23-lactone. Arch Biochem Biophys 1985 0.92
14 Antagonistic action of novel 1alpha,25-dihydroxyvitamin D3-26, 23-lactone analogs on differentiation of human leukemia cells (HL-60) induced by 1alpha,25-dihydroxyvitamin D3. J Biol Chem 1999 0.91
15 Effects of dexamethasone on rhinovirus infection in cultured human tracheal epithelial cells. Am J Physiol Lung Cell Mol Physiol 2000 0.91
16 23(S),25(R)-1,25-dihydroxyvitamin D3-26,23-lactone stimulates murine bone formation in vivo. Endocrinology 1990 0.91
17 Metabolic pathway to 25-hydroxyvitamin D3-26,23-lactone from 25-hydroxyvitamin D3. FEBS Lett 1982 0.90
18 Interstitial pneumonia possibly due to a novel anticancer drug, TS-1: first case report. Jpn J Clin Oncol 2001 0.90
19 Bioactive products of arginine in sepsis: tissue and plasma composition after LPS and iNOS blockade. Am J Physiol Cell Physiol 2000 0.90
20 Effects of 1,25-dihydroxyvitamin D3 on osteoblastic MC3T3-E1 cells. Endocrinology 1986 0.89
21 Infection of human respiratory submucosal glands with rhinovirus: effects on cytokine and ICAM-1 production. Am J Physiol 1999 0.89
22 Analysis of the molecular mechanism for the antagonistic action of a novel 1alpha,25-dihydroxyvitamin D(3) analogue toward vitamin D receptor function. J Biol Chem 1999 0.87
23 Metabolic pathways from 1 alpha,25-dihydroxyvitamin D3 to 1 alpha,25-dihydroxyvitamin D3-26,23-lactone. Stereo-retained and stereo-selective lactonization. J Biol Chem 1987 0.86
24 Chemistry and antimicrobial activity of caryoynencins analogs. J Med Chem 1995 0.86
25 1,25-Dihydroxyvitamin D and three low-calcemic analogs decrease UV-induced DNA damage via the rapid response pathway. J Steroid Biochem Mol Biol 2004 0.86
26 The difference of biological activity among four diastereoisomers of 1 alpha,25-dihydroxycholecalciferol-26,23-lactone. J Steroid Biochem 1986 0.86
27 Activation of epidermal growth factor receptor in the early phase after renal ischemia-reperfusion in rat. Nephron 1999 0.86
28 Suppression of inducible nitric oxide generation by agmatine aldehyde: beneficial effects in sepsis. J Cell Physiol 2001 0.86
29 Exhaled carbon monoxide levels during treatment of acute asthma. Eur Respir J 1999 0.86
30 The unique action for bone metabolism of 1 alpha,25-(OH)2D3-26,23-lactone. Biochem Biophys Res Commun 1985 0.85
31 Different molecular mechanisms of vitamin D(3) receptor antagonists. Mol Pharmacol 2001 0.85
32 Phenotypic differentiation-linked growth inhibition in human leukemia cells by active vitamin D3 analogues. Int J Cancer 1984 0.84
33 Malignant pleural mesothelioma produces functional granulocyte-colony stimulating factor. Chest 2001 0.83
34 1alpha,25-dihydroxyvitamin D(3)-26,23-lactone analogs antagonize differentiation of human leukemia cells (HL-60 cells) but not of human acute promyelocytic leukemia cells (NB4 cells). FEBS Lett 1999 0.83
35 Chaotic responses of the hippocampal CA3 region to a mossy fiber stimulation in vitro. Brain Res 1995 0.82
36 Biological activity assessment of 1 alpha,25-dihydroxyvitamin D3-26,23-lactone in the rat. J Steroid Biochem 1984 0.82
37 Depressive mood is independently related to stroke and cardiovascular events in a community. Biomed Pharmacother 2005 0.82
38 Chronomic community screening reveals about 31% depression, elevated blood pressure and infradian vascular rhythm alteration. Biomed Pharmacother 2004 0.82
39 Studies on the mechanism of action of 1 alpha, 24-dihydroxyvitamin D3. II. Specific binding of alpha, 24-dihydroxyvitamin D3 to chick intestinal receptor. Steroids 1981 0.80
40 Relation between exhaled carbon monoxide levels and clinical severity of asthma. Clin Exp Allergy 2001 0.80
41 Reduction of the voltage-dependent calcium current in Aplysia neurons by pentobarbital. Cell Mol Neurobiol 1986 0.80
42 Human osteoblasts in culture metabolize both 1 alpha, 25-dihydroxyvitamin D3 and its precursor 25-hydroxyvitamin D3 into their respective lactones. Endocrinology 1995 0.79
43 Sarcoid granulomas metabolize 25-hydroxyvitamin D3 in vitro. Biochem Biophys Res Commun 1984 0.79
44 Effects of novel 26,27-dialkyl analogs of 1 alpha,25-dihydroxyvitamin D3 on differentiation-inducing activity of human promyelocytic leukemia (HL-60) cells in serum-supplemented or serum-free culture. Steroids 1991 0.79
45 [Lipid peroxidation and tubular disorder in experimental acute renal failure-enzymochemical study in the rat kidney]. Nihon Jinzo Gakkai Shi 1994 0.79
46 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change. Mol Endocrinol 2000 0.79
47 [A case of myeloperoxidase-specific antineutrophil cytoplasmic antibody (MPO-ANCA)-related glomerulonephritis associated with Cogan's syndrome]. Nihon Jinzo Gakkai Shi 1996 0.78
48 Synthesis and biological activity of 2-methyl-20-epi analogues of 1 alpha,25-dihydroxyvitamin D3. Bioorg Med Chem Lett 1998 0.78
49 Effects of vitamin D-binding proteins on HL-60 cell differentiation induced by 26,26,26,27,27,27-hexafluoro-1 alpha,25-dihydroxyvitamin D. J Steroid Biochem Mol Biol 1992 0.78
50 Vitamin D inhibits endothelial cell migration. Arch Dermatol Res 1996 0.78
51 Natural 25,26-dihydroxyvitamin D3 is an epimeric mixture. Proc Natl Acad Sci U S A 1983 0.77
52 The influence of hypoxia and hyperoxia on the kinetics of propofol emulsion. Can J Anaesth 1999 0.77
53 Isolation and identification of 25-hydroxyvitamin D3-26,23-peroxylactone. A novel in vivo metabolite of vitamin D3. J Biol Chem 1982 0.77
54 Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1 alpha-OHD3) and 1, 24 Dihydroxycholecalciferol (1, 24(OH)2D3). Endocrinol Jpn 1985 0.77
55 Isolation and identification of 1 alpha,25-dihydroxy-24-oxovitamin D3, 1 alpha,25-dihydroxyvitamin D3 26,23-lactone, and 1 alpha,24(S),25-trihydroxyvitamin D3: in vivo metabolites of 1 alpha,25-dihydroxyvitamin D3. Biochemistry 1984 0.76
56 Metabolism of 1alpha,25-dihydroxyvitamin D(3) in human promyelocytic leukemia (HL-60) cells: in vitro biological activities of the natural metabolites of 1alpha,25-dihydroxyvitamin D(3) produced in HL-60 cells. Steroids 2001 0.76
57 Biochemical renal manifestations induced by consecutive administration of gentamicin in rats. Nephron 1998 0.76
58 Simultaneous inhibition of renal phospholipase A(2) and glutathione synthesis by manoalide and DL-buthionine sulfoximine induces acute tubular dysfunction in rats. Exp Nephrol 2000 0.76
59 Dietary sugar beet fiber prevents the increase in aberrant crypt foci induced by gamma-irradiation in the colorectum of rats treated with an immunosuppressant. J Nutr 2000 0.75
60 Cough syncope treated with imidapril in an elderly patient with dysphagia. Chest 2000 0.75
61 Modification of 1 alpha,25-dihydroxyvitamin D3 metabolism by introduction of 26,26,26,27,27,27-hexafluoro atoms in human promyelocytic leukaemia (HL-60) cells: isolation and identification of a novel bioactive metabolite, 26,26,26,27,27,27-hexafluoro-1 alpha,23(S),25-trihydroxyvitamin D3. Biochem J 1993 0.75
62 Effects of arsenic trioxide (As2O3) on the uptake of 3H-thymidine in lymphocytes of mice. Bull Tokyo Dent Coll 1980 0.75
63 Methionine transfer RNA from insect tissue. J Biochem 1974 0.75
64 Study of the control of development of experimental dental caries by changing amino acid pattern of protein in diet. (report 2). Bull Tokyo Dent Coll 1974 0.75
65 Synthesis of (24S)- and (24R)-1 alpha-hydroxy-[24-3H]-cholecalciferol. J Steroid Biochem 1979 0.75
66 Metabolism of 25-hydroxycholecalciferol in human promyelocytic leukemia cells (HL-60). Isolation and identification of (5Z)- and (5E)-19-nor-10-oxo-25-hydroxycholecalciferol. Eur J Biochem 1986 0.75
67 Systematic studies on synthesis, structural elucidation, and biological evaluation of A-ring diastereomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) and 20-epi-2-methyl-1alpha,25-dihydroxyvitamin D(3). Steroids 2001 0.75
68 In vitro 25-hydroxylation of 1 alpha,24-dihydroxyvitamin D3 in various rat tissues. FEBS Lett 1980 0.75
69 Biological activity assessment of 25-hydroxyvitamin D3-26,23-lactone in the rat. FEBS Lett 1982 0.75
70 [A case of preoperatively diagnosed cholangiocarcinoma associated with hepatolithiasis]. Nihon Shokakibyo Gakkai Zasshi 1984 0.75
71 The initiator amino acid in silk fibroin biosynthesis. FEBS Lett 1974 0.75
72 [Two cases of Morgagni's hernia]. Nihon Kyobu Geka Gakkai Zasshi 1993 0.75
73 [New technology of automated blood cell differential counting]. Rinsho Byori 1998 0.75
74 The role of vitamin D metabolites in hypercalcemia of Zucker fa/fa rats. J Nutr Sci Vitaminol (Tokyo) 1985 0.75
75 [Histological identification of brainstem neurons related to generation of rhythmical jaw movements in the rat]. Fukuoka Igaku Zasshi 2000 0.75
76 [Clinical investigation of 10 cases with acute renal failure induced by neuroleptics]. Nihon Jinzo Gakkai Shi 1996 0.75
77 Study of the control of development of experimental dental caries by changing amino acid pattern of protein in diet. (report 1) Bull Tokyo Dent Coll 1974 0.75
78 An efficient synthesis of N-tert-butoxycarbonyl-O-cyclohexyl-L-tyrosine. Chem Pharm Bull (Tokyo) 2001 0.75
79 Small optical magnetic-field sensor that uses rare-Earth iron garnet films based on the faraday effect. Appl Opt 1999 0.75
80 O-(N-succinimidyl)-1,1,3,3-tetramethyluronium tetrafluoroborate-N-hydroxysuccinimide-CuCl2: a facile and reliable system for racemization-free coupling of peptides having a carboxy-terminal N-methylamino acid. Chem Pharm Bull (Tokyo) 2000 0.75
81 Effect of 24,25-dihydroxyvitamin D3 on 1,25-dihydroxyvitamin D3 [1,25-(OH)2D3] metabolism in vitamin D-deficient rats infused with 1,25-(OH)2D3. Endocrinology 1989 0.75
82 [A case of Meckel's diverticulum caused intestinal obstruction of loop formation and strunglated intestine by adhesion]. Nihon Shokakibyo Gakkai Zasshi 1997 0.75
83 [Anti-inflammatory effect of Aesculus extract]. Shikwa Gakuho 1967 0.75
84 Corticotrigeminal motor pathway in the rat--II. Anterio- and retrograde HRP labeling. Comp Biochem Physiol A Comp Physiol 1989 0.75
85 Murine recombinant leukemia inhibitory factor modulates inhibitory effect of 1,25 dihydroxyvitamin D3 on alkaline phosphatase activity in MC3T3-E1 cells. Biochem Biophys Res Commun 1991 0.75
86 [The registered nurse and the practical nurse in the hospital]. Kango 1979 0.75
87 A case of partial carnitine palmitoyltransferase deficiency in a patient undergoing chronic hemodialysis. Am J Nephrol 2001 0.75
88 [A case of multiple organ failure induced by postoperative radiation therapy probably evoking oxidative stress]. Nihon Jinzo Gakkai Shi 1995 0.75
89 Long-term change in synaptic transmission in CA3 circuits followed by spontaneous rhythmic activity in rat hippocampal slices. Neurosci Res 2001 0.75
90 Synthesis and biological activity of 1 alpha,23,25,26-tetrahydroxyvitamin D3. Arch Biochem Biophys 1987 0.75
91 Novel vitamin D3 derivatives, 26-homo-delta 22-dehydro-1 alpha,25(S)-dihydroxyvitamin D3 and 26-homo-delta 22-dehydro-1 alpha,25(R)-dihydroxyvitamin D3: preferential activity in c-myc mRNA production and in induction of phenotypic differentiation of HL-60 cells. Arch Biochem Biophys 1990 0.75
92 [Pharmacological study of a protease TSP-X produced by Serratia sp. E 15]. Nihon Yakurigaku Zasshi 1968 0.75
93 Induction of heme oxygenase-1 in toxic renal injury: mercuric chloride-induced acute renal failure in rat. Toxicol Lett 1998 0.75
94 Stereo-retained and stereo-selective lactonization of four diastereoisomers of 23,25,26-trihydroxyvitamin D3 in homogenates of kidney from vitamin D-supplemented chicks. Arch Biochem Biophys 1984 0.75
95 [A case of refractory pulmonary fistula, managed with bronchoscopic therapy using occluding spiral embolus]. Kyobu Geka 1998 0.75
96 Effect of 1,25-dihydroxyvitamin D3 on pancreatic B and D cell function. Life Sci 1983 0.75
97 Isolation, identification, and biological activity of 23,25,26-trihydroxyvitamin D3, an in vitro and in vivo metabolite of vitamin D3. Arch Biochem Biophys 1982 0.75
98 Effects of streptozotocin-induced diabetes on circulating levels of vitamin D metabolites. Acta Endocrinol (Copenh) 1983 0.75
99 Biological activity of vitamin D3 derivatives in inducing differentiation of HL-60 human promyelocytic leukemia cells. J Pharmacobiodyn 1984 0.75
100 Reduction of renal transforming growth factor-beta activity without aggravation of growth retardation in nephritic rats by a methionine-threonine-supplemented low-casein diet. Biosci Biotechnol Biochem 1997 0.75
101 Kinetic analysis of acetylcholine-induced chloride current in isolated snail neurons. Cell Mol Neurobiol 1988 0.75
102 The 1 alpha-hydroxylation of 24-hydroxyvitamin D3 by chick kidney homogenates. Arch Biochem Biophys 1983 0.75
103 Isolation and identification of 1alpha-hydroxy-24-oxovitamin D3 and 1alpha,23-dihydroxy-24-oxovitamin D3: metabolites of 1alpha,24(R)-dihydroxyvitamin D3 produced in rat kidney. Biochem Pharmacol 1999 0.75
104 Studies on the mechanism of action of 1 alpha,24-dihyroxyvitamin D3. I. Synthesis of 1 alpha,24(R) and 1 alpha,24(S)-dihydroxy-[24-3H]vitamin D3 and their metabolism in the rat. J Biochem 1980 0.75
105 Effects of insulin on altered mineral and vitamin D metabolism in streptozotocin-induced diabetes. Acta Endocrinol (Copenh) 1985 0.75
106 Real-time measurement of wavelength selectivity of reflection holograms. Appl Opt 1992 0.75
107 [Anti-inflammatory effects of the extract of Aesculus hippocastanum L. (horse chesnut) seed]. Shikwa Gakuho 1967 0.75
108 Effects of 1 alpha, 25-dihydroxyvitamin D3-26,23-lactone and its intermediate metabolites on bone metabolism in vivo and in vitro. Contrib Nephrol 1991 0.75
109 Circulating levels of vitamin D metabolites in patients with hyperinsulinaemia. Hum Nutr Clin Nutr 1984 0.75
110 Human myeloid leukemia cells metabolize 25-hydroxyvitamin D3 in vitro. Biochem Biophys Res Commun 1985 0.75
111 Three-dimensional (BiY)(3)Fe(5)O(12) waveguide with a load layer made of SiO(2). Appl Opt 1991 0.75
112 Vitamin D in bone formation. Osteoporos Int 1993 0.75
113 Radioreceptor assay for 1 alpha,24(R)25-trihydroxyvitamin D3 in human serum. J Nutr Sci Vitaminol (Tokyo) 1981 0.75
114 The stereochemical configuration of the natural 23,25,26-trihydroxyvitamin D3. FEBS Lett 1983 0.75
115 Intrinsic biological activities by 1 alpha,24-dihydroxyvitamin D3 in the rat. Biochem Biophys Res Commun 1979 0.75
116 Propofol pharmacokinetics in a dwarfism patient. Acta Anaesthesiol Scand 2003 0.75
117 [Effect of aging on bone mineral contents. Part IV: Normal range and physiological importance of serum vitamin D metabolites and parathyroid hormone (PTH) levels in healthy aged females]. Nihon Ronen Igakkai Zasshi 1985 0.75
118 [A case report of chylothorax caused by thrombotic obstruction of jugulo-subclavian veins]. Kyobu Geka 1987 0.75
119 Synthesis and biological activity of (22E,25R)- and (22,25S)-22-dehydro- 1 alpha,25-dihydroxy-26-methylvitamin D3. J Steroid Biochem 1990 0.75
120 Studies on the mechanism of action of 1 alpha,24-dihydroxyvitamin D3. III. The specific binding of 1 alpha,24-dihydroxyvitamin D3 to the receptor of chick parathyroid gland. Steroids 1982 0.75
121 Synthesis and biological evaluation of 1alpha,24-dihydroxy-25-nitrovitamin D3. Bioorg Med Chem Lett 1999 0.75
122 [Four-week repeated dose oral toxicity study of BMY-28100 in juvenile beagle dogs]. Jpn J Antibiot 1990 0.75
123 Naturally occurring 24,25-dihydroxyvitamin D3 is a mixture of both C-24R and C-24S epimers. Arch Biochem Biophys 1984 0.75